TOKYO, Jun 15 (Pulse News Wire) – RIBOMIC Inc. (4591.T) plans to amend its articles of incorporation during its 23rd Annual General Meeting scheduled for June 23, 2026.
The proposed amendment aims to prepare for potential future funding needs due to ongoing research and development investments, particularly those related to clinical pipeline advancements. The company recognizes the importance of maintaining shareholder value and cautions against easy equity financing during low stock price periods. However, RIBOMIC believes that securing flexible capital policy options now could mitigate risks associated with delayed responses to future funding requirements.
The proposal does not commit to immediate issuance but sets up a framework to ensure long-term flexibility without causing immediate dilution. In addition to exploring non-dilutive funding methods such as licensing deals and revenue-sharing agreements, RIBOMIC emphasizes that the proposed changes are primarily aimed at broadening future capital strategy options rather than being tied to specific funding mechanisms. There are currently no plans for issuing additional warrants or shares beyond existing allotments.
🟢 Confidence: High AI-translated content.